Allecra Therapeutics raised €22M in a Series B round in Jun 2016. The company is based in Weil am Rhein, Germany. Investors in the round: Delos Capital, Edmond de Rothschild Venture Capital, EMBL Ventures and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €22M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
